|
|
| (4 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| − | *'''[[Prophylaxis of Thrombembolism]]'''
| |
| | | | |
| | + | {{ft|A}} |
| | + | *'''[[Prophylaxis of Thrombembolism]]''' |
| | + | *'''[https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/ The AAP has developed guidance on the following topics: American Academy of Pediatrics]]''' |
| | *'''[https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/ IDSA current Covid guidelines]''' | | *'''[https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/ IDSA current Covid guidelines]''' |
| | {{tp|p=32398287|t=2020. Covid-19: What is the R number?|pdf=|usr=007}} | | {{tp|p=32398287|t=2020. Covid-19: What is the R number?|pdf=|usr=007}} |
| Zeile 261: |
Zeile 263: |
| | {{tp|p=32583345|t=2020. Charlson Comorbidity Index Score and Risk of Severe Outcome and Death in Danish COVID-19 Patients.|pdf=|usr=011}} | | {{tp|p=32583345|t=2020. Charlson Comorbidity Index Score and Risk of Severe Outcome and Death in Danish COVID-19 Patients.|pdf=|usr=011}} |
| | {{tp|p=32603535|t=2020. Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID-19 patients: Multicenter retrospective study.|pdf=|usr=011}} | | {{tp|p=32603535|t=2020. Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID-19 patients: Multicenter retrospective study.|pdf=|usr=011}} |
| − |
| |
| − |
| |
| − | 012
| |
| − |
| |
| − |
| |
| − |
| |
| − | {{tp|p=32654005|t=2020. Improving the care of older patients during the COVID-19 pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32666026|t=2020. Expert consensus on protocol of rehabilitation for COVID-19 patients using framework and approaches of WHO International Family Classifications.|pdf=|usr=014}}
| |
| − | {{tp|p=32712236|t=2020. Propofol in COVID 19 - From basic science to clinical impact.|pdf=|usr=014}}
| |
| − | {{tp|p=32713604|t=2020. Consistency and reliability of COVID-19 projection models as a means to save lives.|pdf=|usr=014}}
| |
| − | {{tp|p=32657818|t=2020. The Down Side of Prone Positioning: The Case of a COVID-19 Survivor.|pdf=|usr=014}}
| |
| − | {{tp|p=32659455|t=2020. No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32628134|t=2020. Evaluation and follow-up of pediatric COVID-19 in terms of cardiac involvement: A scientific statement from the Association of Turkish Pediatric Cardiology and Pediatric Cardiac Surgery.|pdf=|usr=014}}
| |
| − | {{tp|p=32675641|t=2020. In Response: The Use of Analgesia and Sedation in Mechanically Ventilated Patients with COVID-19 ARDS.|pdf=|usr=014}}
| |
| − | {{tp|p=32692228|t=2020. Clinical outcome of standardized oxygen therapy nursing strategy in COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32687823|t=2020. Extracorporeal Membrane Oxygenation Support in Severe COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32682580|t=2020. Mechanical Risks of Ventilator Sharing in the COVID-19 Era: A Simulation-Based Study.|pdf=|usr=014}}
| |
| − | {{tp|p=32654852|t=2020. Biologic Therapy in COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32691074|t=2020. A putative AOP for pneumonia related to COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32695275|t=2020. COVID-19 and Medical Biotechnology.|pdf=|usr=014}}
| |
| − | {{tp|p=32665967|t=2020. Machine learning to assist clinical decision-making during the COVID-19 pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32689937|t=2020. Management of Respiratory Distress Syndrome due to COVID-19 infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32664944|t=2020. Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.|pdf=|usr=014}}
| |
| − | {{tp|p=32694132|t=2020. Update to living systematic review on prediction models for diagnosis and prognosis of covid-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32682550|t=2020. Interdependence between elevated intra-abdominal, pleural, and airway opening pressure in severe acute respiratory distress syndrome with extracorporeal membrane oxygenation.|pdf=|usr=014}}
| |
| − | {{tp|p=32680606|t=2020. Airway management lessons from case reports of negative outcomes. Comment on Br J Anaesth; 125: e168-70.|pdf=|usr=014}}
| |
| − | {{tp|p=32698378|t=2020. COVID-19: Pain Management in Patients with SARS-CoV-2 Infection-Molecular Mechanisms, Challenges, and Perspectives.|pdf=|usr=014}}
| |
| − | {{tp|p=32713829|t=2020. Management of COVID-19 in burns patients: The experience of a UK burn centre.|pdf=|usr=014}}
| |
| − | {{tp|p=32712309|t=2020. The Basics of ARDS Mechanical Ventilatory Care for Cardiovascular Specialists.|pdf=|usr=014}}
| |
| − | {{tp|p=32681847|t=2020. "How I Do It: High Flow, Non-invasive ventilation and Awake (non-intubation) Proning in Covid-19 Patients with Respiratory Failure".|pdf=|usr=014}}
| |
| − | {{tp|p=32679237|t=2020. Prone and Lateral Positioning in Spontaneously Breathing Patients With COVID-19 Pneumonia Undergoing Noninvasive Helmet CPAP Treatment.|pdf=|usr=014}}
| |
| − | {{tp|p=32680896|t=2020. Evaluation and management of shock in patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32683854|t=2020. COVID-19: challenges and opportunities.|pdf=|usr=014}}
| |
| − | {{tp|p=32683801|t=2020. Overview of Management of Children with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32664708|t=2020. COVID-19 in children: reasons for uneventful clinical course.|pdf=|usr=014}}
| |
| − | {{tp|p=32675168|t=2020. NEWS2 system requires modification to identify deteriorating patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32675139|t=2020. Research in brief: Prone positioning in COVID-19: What's the evidence.|pdf=|usr=014}}
| |
| − | {{tp|p=32622952|t=2020. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.|pdf=|usr=014}}
| |
| − | {{tp|p=32688137|t=2020. Non Pharmaceutical Interventions for Optimal Control of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32700405|t=2020. Initiation of Antiviral Treatment in SARS-CoV2: Modeling Viral Dynamics and Drug Properties.|pdf=|usr=014}}
| |
| − | {{tp|p=32684170|t=2020. Nutrition of the COVID-19 patient in the intensive care unit (ICU): a practical guidance.|pdf=|usr=014}}
| |
| − | {{tp|p=32678040|t=2020. Development and validation of a risk factor-based system to predict short-term survival in adult hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.|pdf=|usr=014}}
| |
| − | {{tp|p=32665007|t=2020. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome.|pdf=|usr=014}}
| |
| − | {{tp|p=32659695|t=2020. Data mining and analysis of scientific research data records on Covid-19 mortality, immunity, and vaccine development - In the first wave of the Covid-19 pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32691020|t=2020. A novel scoring system in mortality prediction of severe patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32685437|t=2020. Proning reduces ventilation heterogeneity in patients with elevated BMI: implications for COVID-19 pneumonia management?|pdf=|usr=014}}
| |
| − | {{tp|p=32665949|t=2020. COVID-19 necrotising pneumonia and extracorporeal membrane oxygenation: a challenge for anticoagulation.|pdf=|usr=014}}
| |
| − | {{tp|p=32620500|t=2020. First comes the A, then the B: what we learned from the COVID-19 outbreak.|pdf=|usr=014}}
| |
| − | {{tp|p=32665174|t=2020. Published evidence on COVID-19 in top-ranked journals: A descriptive study.|pdf=|usr=014}}
| |
| − | {{tp|p=32693298|t=2020. COVID-19 treatment: Much research and testing, but far, few magic bullets against SARS-CoV-2 coronavirus.|pdf=|usr=014}}
| |
| − | {{tp|p=32682788|t=2020. Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32703773|t=2020. COVID-19 prediction models should adhere to methodological and reporting standards.|pdf=|usr=014}}
| |
| − | {{tp|p=32675213|t=2020. Awake Prone Positioning for Non-intubated Oxygen Dependent COVID-19 Pneumonia Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32675212|t=2020. COVID-19 conundrum: Clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness.|pdf=|usr=014}}
| |
| − | {{tp|p=32675205|t=2020. Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study.|pdf=|usr=014}}
| |
| − | {{tp|p=32482788|t=2020. The perils of premature phenotyping in COVID-19: a call for caution.|pdf=|usr=014}}
| |
| − | {{tp|p=32430433|t=2020. A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019.|pdf=|usr=014}}
| |
| − | {{tp|p=32661338|t=2020. Comment on: "Care for critically ill patients with COVID-19: don't forget the eyes".|pdf=|usr=014}}
| |
| − | {{tp|p=32714921|t=2020. From Farm to Finger Prick-A Perspective on How Plants Can Help in the Fight Against COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32700145|t=2020. COVID-19 in Different Age Groups of Children: Initial Impression from Integrated Disease Surveillance Programme (IDSP) under National Centre for Disease Control (NCDC).|pdf=|usr=014}}
| |
| − | {{tp|p=32651306|t=2020. Epidemiology and Clinical Features of Coronavirus Disease 2019 in Moroccan Children.|pdf=|usr=014}}
| |
| − | {{tp|p=32708196|t=2020. A Comprehensive Mapping of the Druggable Cavities within the SARS-CoV-2 Therapeutically Relevant Proteins by Combining Pocket and Docking Searches as Implemented in Pockets 2.0.|pdf=|usr=014}}
| |
| − | {{tp|p=32708112|t=2020. COVID-19: A Review on Diagnosis, Treatment, and Prophylaxis.|pdf=|usr=014}}
| |
| − | {{tp|p=32710146|t=2020. Integrating the evidence: confronting the COVID-19 elephant.|pdf=|usr=014}}
| |
| − | {{tp|p=32710161|t=2020. Therapie schwerer COVID-19-Verlaufe in der Intensivmedizin.|pdf=|usr=014}}
| |
| − | {{tp|p=32705298|t=2020. Die Virologie von SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32710975|t=2020. Interleukin-6-based mortality risk model for hospitalised COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32705880|t=2020. No protocol and no liability: a call for COVID crisis guidelines that protect vulnerable populations.|pdf=|usr=014}}
| |
| − | {{tp|p=32720239|t=2020. Primary Care Population Management for COVID-19 Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32717144|t=2020. Cultivating a Better Understanding of COVID-19 Amidst a Shifting Landscape.|pdf=|usr=014}}
| |
| − | {{tp|p=32685980|t=2020. Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32685975|t=2020. RE: EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED-UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS.|pdf=|usr=014}}
| |
| − | {{tp|p=32685969|t=2020. Commentary: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis".|pdf=|usr=014}}
| |
| − | {{tp|p=32685966|t=2020. Response to: "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients" and "Re: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis".|pdf=|usr=014}}
| |
| − | {{tp|p=32685962|t=2020. Response to: Comment on "Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients That Should be Ramped-Up Immediately as Key to the Pandemic Crisis".|pdf=|usr=014}}
| |
| − | {{tp|p=32687760|t=2020. Recommendations for caring for patients with severe and nonsevere COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32669360|t=2020. COVID-19: minimising contaminated aerosol spreading during CPAP treatment.|pdf=|usr=014}}
| |
| − | {{tp|p=32657601|t=2020. SARS-CoV-2; What We Know so far.|pdf=|usr=014}}
| |
| − | {{tp|p=32701627|t=2020. Specific considerations for venovenous-extracorporeal membrane oxygenation during Coronavirus Disease-2019 pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32715659|t=2020. Coronavirus disease 2019 pandemic and identifying insufflators with desufflation mode and surgical smoke evacuators for safe CO2 removal.|pdf=|usr=014}}
| |
| − | {{tp|p=32680422|t=2020. Comprehensive Review on Current Interventions, Diagnostic, and Nanotechnology Perspectives against SARS-CoV-2.|pdf=|usr=014}}
| |
| − | {{tp|p=32690476|t=2020. Covid-19: Study reveals six clusters of symptoms that could be used as a clinical prediction tool.|pdf=|usr=014}}
| |
| − | {{tp|p=32665317|t=2020. Covid-19: What do we know about "long covid"?|pdf=|usr=014}}
| |
| − | {{tp|p=32654267|t=2020. The recent challenges of highly contagious COVID-19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy.|pdf=|usr=014}}
| |
| − | {{tp|p=32628752|t=2020. Simple 'Rule-of-6' predicts severe COVID-19 disease.|pdf=|usr=014}}
| |
| − | {{tp|p=32674129|t=2020. Nasopharyngeal SARS-CoV-2 load at hospital admission as predictor of mortality.|pdf=|usr=014}}
| |
| − | {{tp|p=32651959|t=2020. Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions.|pdf=|usr=014}}
| |
| − | {{tp|p=32693757|t=2020. A Case Study: Analysis of Patents of Coronaviruses and Covid-19 for Technology Assesment and Future Research.|pdf=|usr=014}}
| |
| − | {{tp|p=32660401|t=2020. COVID-19 Outbreak and Emerging Management through Pharmaceutical Therapeutic Strategy|pdf=|usr=014}}
| |
| − | {{tp|p=32651978|t=2020. COVID-19: making the right diagnosis.|pdf=|usr=014}}
| |
| − | {{tp|p=32713542|t=2020. Emerging pathogens and COVID-19: A brief introduction.|pdf=|usr=014}}
| |
| − | {{tp|p=32713387|t=2020. Prone Positioning in Non-intubated Patients with COVID-19 Outside the Intensive Care Unit: More Evidence Needed.|pdf=|usr=014}}
| |
| − | {{tp|p=32716648|t=2020. The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options.|pdf=|usr=014}}
| |
| − | {{tp|p=32651176|t=2020. Evidence-based medicine and COVID-19: what to believe and when to change.|pdf=|usr=014}}
| |
| − | {{tp|p=32703036|t=2020. Integrative role of traditional and modern technologies to combat COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32674622|t=2020. Emerging technologies for diagnostics and drug delivery in the fight against COVID-19 and other pandemics.|pdf=|usr=014}}
| |
| − | {{tp|p=32701376|t=2020. Analysis of prediction and early warning indexes of patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32710533|t=2020. Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History.|pdf=|usr=014}}
| |
| − | {{tp|p=32697030|t=2020. Beneficial effect of awake prone position in hypoxaemic patients with COVID-19: case reports and literature review.|pdf=|usr=014}}
| |
| − | {{tp|p=32710973|t=2020. Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities.|pdf=|usr=014}}
| |
| − | {{tp|p=32674221|t=2020. Comment on: COVID-19 and Older Adults: What We Know.|pdf=|usr=014}}
| |
| − | {{tp|p=32662571|t=2020. Opportunities for Biomaterials to Address the Challenges of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32686993|t=2020. Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants.|pdf=|usr=014}}
| |
| − | {{tp|p=32717771|t=2020. Role of extracorporeal membrane oxygenation in COVID-19: A systematic review.|pdf=|usr=014}}
| |
| − | {{tp|p=32678961|t=2020. Extracorporeal membrane oxygenation and COVID-19: The causes of failure.|pdf=|usr=014}}
| |
| − | {{tp|p=32668041|t=2020. COVID-19 patient bridged to recovery with veno-venous extracorporeal membrane oxygenation.|pdf=|usr=014}}
| |
| − | {{tp|p=32660309|t=2020. COVID-19: A Review for the Pediatric Neurologist.|pdf=|usr=014}}
| |
| − | {{tp|p=32675738|t=2020. Exercise, nutrition, and medication considerations in the light of the COVID pandemic, with specific focus on geriatric population: A literature review.|pdf=|usr=014}}
| |
| − | {{tp|p=32703894|t=2020. The COVID-19 Diagnostic Dilemma: a Clinician's Perspective.|pdf=|usr=014}}
| |
| − | {{tp|p=32703893|t=2020. My Experience with SARS-CoV-2, with a Focus on Testing.|pdf=|usr=014}}
| |
| − | {{tp|p=32703888|t=2020. What Is Needed for the Response to COVID-19? A Micro-Comic Strip.|pdf=|usr=014}}
| |
| − | {{tp|p=32643436|t=2020. Pharmacological and non-pharmacological efforts at prevention, mitigation, and treatment for COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32666676|t=2020. The use of mechanistic reasoning in assessing coronavirus interventions.|pdf=|usr=014}}
| |
| − | {{tp|p=32677498|t=2020. The Ventilator Management Team: Repurposing Anesthesia Workstations and Personnel to Combat COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32700681|t=2020. Treating COVID-19: Review of drug hypersensitivity reactions.|pdf=|usr=014}}
| |
| − | {{tp|p=32710639|t=2020. A Structural Equation Model to Examine the Clinical Features of Mild-to-Moderate Covid-19: A Multicenter Italian Study.|pdf=|usr=014}}
| |
| − | {{tp|p=32706390|t=2020. The mechanistic rationale of drugs, Primary endpoints, Geographical distribution of clinical trials against Severe acute respiratory syndrome-related coronavirus-2: A Systematic Review.|pdf=|usr=014}}
| |
| − | {{tp|p=32667699|t=2020. Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.|pdf=|usr=014}}
| |
| − |
| |
| − | {{tp|p=32691016|t=2020. Why lockdown? Why national unity? Why global solidarity? Simplified arithmetic tools for decision-makers, health professionals, journalists and the general public to explore containment options for the 2019 novel coronavirus.|pdf=|usr=014}}
| |
| − | {{tp|p=32690096|t=2020. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.|pdf=|usr=014}}
| |
| − | {{tp|p=32617010|t=2020. Indicators of Critical Illness and Predictors of Mortality in COVID-19 Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32692258|t=2020. Extracorporeal Membrane Oxygenation for COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32679328|t=2020. Application prospect of polysaccharides in the development of anti-novel coronavirus drugs and vaccines.|pdf=|usr=014}}
| |
| − | {{tp|p=32674450|t=2020. Clinical Presentation of COVID-19: Case Series and Review of the Literature.|pdf=|usr=014}}
| |
| − | {{tp|p=32668763|t=2020. Correlations of Clinical and Laboratory Characteristics of COVID-19: A Systematic Review and Meta-Analysis.|pdf=|usr=014}}
| |
| − | {{tp|p=32702415|t=2020. Epidemiological and Clinical Characteristics of Coronavirus Disease 2019 in Daegu, South Korea.|pdf=|usr=014}}
| |
| − | {{tp|p=32663601|t=2020. Silent Hypoxia in Patients with SARS CoV-2 Infection before Hospital Discharge.|pdf=|usr=014}}
| |
| − | {{tp|p=32714083|t=2020. Advances and challenges in the prevention and treatment of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32714077|t=2020. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.|pdf=|usr=014}}
| |
| − | {{tp|p=32699915|t=2020. Efficacy of early prone position for COVID-19 patients with severe hypoxia: a single-center prospective cohort study.|pdf=|usr=014}}
| |
| − | {{tp|p=32671470|t=2020. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure.|pdf=|usr=014}}
| |
| − | {{tp|p=32654006|t=2020. Emerging pharmacological therapies for ARDS: COVID-19 and beyond.|pdf=|usr=014}}
| |
| − | {{tp|p=32622261|t=2020. Current Status of COVID-19 Therapies and Drug Repositioning Applications.|pdf=|usr=014}}
| |
| − | {{tp|p=32661197|t=2020. The molecular virology of Coronaviruses.|pdf=|usr=014}}
| |
| − | {{tp|p=32696838|t=2020. Should all COVID-19 patients be approached in the same way?|pdf=|usr=014}}
| |
| − | {{tp|p=32696835|t=2020. COVID-19 pandemic and mechanical ventilation: facing the present, designing the future.|pdf=|usr=014}}
| |
| − | {{tp|p=32661797|t=2020. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32674306|t=2020. Epidemiology and Clinical Presentation of Children Hospitalized with SARS-CoV-2 Infection in Suburbs of Paris.|pdf=|usr=014}}
| |
| − | {{tp|p=32683213|t=2020. Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32671115|t=2020. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention.|pdf=|usr=014}}
| |
| − | {{tp|p=32683343|t=2020. Improving the early diagnosis of suspected patients with COVID-19: a retrospective study of 106 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32684351|t=2020. An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics.|pdf=|usr=014}}
| |
| − | {{tp|p=32682658|t=2020. Comparing Chinese children and adults with RT-PCR positive COVID-19: A systematic review.|pdf=|usr=014}}
| |
| − | {{tp|p=32715674|t=2020. Do We Really Need to Isolate All Children with COVID-19 in Healthcare Facilities?|pdf=|usr=014}}
| |
| − | {{tp|p=32696264|t=2020. The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections.|pdf=|usr=014}}
| |
| − | {{tp|p=32681989|t=2020. Clinical Manifestations and Outcomes of Critically Ill Children and Adolescents with COVID-19 in New York City.|pdf=|usr=014}}
| |
| − | {{tp|p=32695427|t=2020. Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspective.|pdf=|usr=014}}
| |
| − | {{tp|p=32657586|t=2020. Proteomics and Informatics for Understanding Phases and Identifying Biomarkers in COVID-19 Disease.|pdf=|usr=014}}
| |
| − | {{tp|p=32654489|t=2020. Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning.|pdf=|usr=014}}
| |
| − | {{tp|p=32703914|t=2020. COVID-19 from the Perspective of a Gastroenterologist.|pdf=|usr=014}}
| |
| − | {{tp|p=32687919|t=2020. A lung for all: Novel mechanical ventilator for emergency and low-resource settings.|pdf=|usr=014}}
| |
| − | {{tp|p=32687917|t=2020. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32629670|t=2020. Failure of early extubation among cases of coronavirus disease-19 respiratory failure: Case report and clinical experience.|pdf=|usr=014}}
| |
| − | {{tp|p=32670520|t=2020. Children in Coronaviruses' Wonderland: What Clinicians Need to Know.|pdf=|usr=014}}
| |
| − | {{tp|p=32681968|t=2020. Clinical characteristics, laboratory findings, radiographic signs and outcomes of 61,742 patients with confirmed COVID-19 infection: A systematic review and meta-analysis.|pdf=|usr=014}}
| |
| − | {{tp|p=32707942|t=2020. Evaluation of Current Therapies for COVID-19 Treatment.|pdf=|usr=014}}
| |
| − | {{tp|p=32671688|t=2020. Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics.|pdf=|usr=014}}
| |
| − | {{tp|p=32669540|t=2020. Early triage of critically ill COVID-19 patients using deep learning.|pdf=|usr=014}}
| |
| − | {{tp|p=32671650|t=2020. SARS-CoV-2/COVID-19: a primer for cardiologists.|pdf=|usr=014}}
| |
| − | {{tp|p=32622086|t=2020. Neurobiology of coronaviruses: Potential relevance for COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32670592|t=2020. Mild SARS-CoV-2 infections in children might be based on evolutionary biology and linked with host reactive oxidative stress and antioxidant capabilities.|pdf=|usr=014}}
| |
| − | {{tp|p=32695885|t=2020. Estimating the efficacy of symptom-based screening for COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32661497|t=2020. An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=014}}
| |
| − | {{tp|p=32677509|t=2020. The Palliative Performance Scale predicts mortality in hospitalized patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32621013|t=2020. Management strategies for children with COVID-19: ESPR practical recommendations.|pdf=|usr=014}}
| |
| − | {{tp|p=32656001|t=2020. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios.|pdf=|usr=014}}
| |
| − | {{tp|p=32706941|t=2020. Agitation Management During the COVID-19 Pandemic: The Time for a Noncoercive Approach Is Now.|pdf=|usr=014}}
| |
| − | {{tp|p=32678526|t=2020. Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation.|pdf=|usr=014}}
| |
| − | {{tp|p=32673191|t=2020. Racial/Ethnic Disparities in Disease Severity on Admission Chest Radiographs among Patients Admitted with Confirmed COVID-19: A Retrospective Cohort Study.|pdf=|usr=014}}
| |
| − | {{tp|p=32653383|t=2020. Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020.|pdf=|usr=014}}
| |
| − | {{tp|p=32698822|t=2020. Continuously available ratio of SpO2/FiO2 serves as a noninvasive prognostic marker for intensive care patients with COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32684644|t=2020. COVID-19: a short message to rheumatologists.|pdf=|usr=014}}
| |
| − | {{tp|p=32667444|t=2020. Diretrizes para o tratamento farmacologico da COVID-19. Consenso da Associacao de Medicina Intensiva Brasileira, da Sociedade Brasileira de Infectologia e da Sociedade Brasileira de Pneumologia e Tisiologia.|pdf=|usr=014}}
| |
| − | {{tp|p=32660623|t=2020. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 - a prospective cohort study.|pdf=|usr=014}}
| |
| − | {{tp|p=32699587|t=2020. SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer.|pdf=|usr=014}}
| |
| − | {{tp|p=32669846|t=2020. Major Neurologic Adverse Drug Reactions, Potential Drug-Drug Interactions and Pharmacokinetic Aspects of Drugs Used in COVID-19 Patients with Stroke: A Narrative Review.|pdf=|usr=014}}
| |
| − | {{tp|p=32651761|t=2020. Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review.|pdf=|usr=014}}
| |
| − | {{tp|p=32658053|t=2020. COVID-19 Trials and Tribulations by Rebecca Gliksman MD MPH.|pdf=|usr=014}}
| |
| − | {{tp|p=32686937|t=2020. SARS-CoV-2 encoded proteome and human genetics: from interaction-based to ribosomal biology impact on disease and risk processes.|pdf=|usr=014}}
| |
| − | {{tp|p=32673407|t=2020. In Response to Anosmia and Ageusia: Common Findings in COVID-19 Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32673402|t=2020. In Reference to Anosmia and Ageusia: Common Findings in COVID-19 Patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32677734|t=2020. Clinical presentation and management of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32651579|t=2020. Extrapulmonary manifestations of COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32694872|t=2020. Five coronavirus questions scientists still don't have answers to.|pdf=|usr=014}}
| |
| − | {{tp|p=32674170|t=2020. Pediatric COVID-19 Disease: A Review of the Recent Literature.|pdf=|usr=014}}
| |
| − | {{tp|p=32710693|t=2020. Insight into the Pediatric and Adult Dichotomy of COVID-19: Age-Related Differences in the Immune Response to SARS-CoV-2 infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32710652|t=2020. Children and COVID-19: Microbiological and immunological insights.|pdf=|usr=014}}
| |
| − | {{tp|p=32712625|t=2020. Shoring up the safety net for children in the COVID-19 pandemic.|pdf=|usr=014}}
| |
| − | {{tp|p=32679582|t=2020. A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children.|pdf=|usr=014}}
| |
| − | {{tp|p=32665373|t=2020. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy.|pdf=|usr=014}}
| |
| − | {{tp|p=32663611|t=2020. Data to guide the application of the new WHO criteria for releasing COVID-19 patients from isolation.|pdf=|usr=014}}
| |
| − | {{tp|p=32691056|t=2020. Prone Positioning of Patients With Acute Respiratory Distress Syndrome Related to COVID-19: A Rehabilitation-Based Prone Team.|pdf=|usr=014}}
| |
| − | {{tp|p=32674191|t=2020. ECMO als Therapie des schweren Lungenversagens bei COVID-19.|pdf=|usr=014}}
| |
| − | {{tp|p=32674190|t=2020. 48-jahriger Triathlet mit schwerer COVID-19-Pneumonie: erfolgreiche und sichere Behandlung mit Sauerstoff und CPAP.|pdf=|usr=014}}
| |
| − | {{tp|p=32692813|t=2020. Use of External Ventilator Control Panel for Mechanical Ventilation in Patients with Severe SARS-CoV-2 Infection.|pdf=|usr=014}}
| |
| − | {{tp|p=32652021|t=2020. Association of Padua prediction score with in-hospital prognosis in COVID-19 patients.|pdf=|usr=014}}
| |
| − | {{tp|p=32713937|t=2020. Covid-19 y salud infantil: el confinamiento y su impacto segun profesionales de la infancia.|pdf=|usr=014}}
| |
| − |
| |
| − | head
| |
| − | {{tp|p=32696002|t=2020. Strategies to Optimize ICU Liberation (A to F) Bundle Performance in Critically Ill Adults With Coronavirus Disease 2019.|pdf=|usr=015}}
| |
| − | {{tp|p=32671351|t=2020. Proposal for Coronavirus Disease 2019 Management.|pdf=|usr=015}}
| |
| − | {{tp|p=32685628|t=2020. Haematological and immunological data of Chinese children infected with coronavirus disease 2019.|pdf=|usr=015}}
| |
| − | {{tp|p=C7332889|t=2020. Scoring systems for predicting mortality for severe patients with COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7318942|t=2020. COVID-19 in 7780 pediatric patients: A systematic review.|pdf=|usr=015}}
| |
| − | {{tp|p=C7301102|t=2020. Severity of respiratory failure and outcome of patients needing a ventilatory support in the Emergency Department during Italian novel coronavirus SARS-CoV2 outbreak: Preliminary data on the role of Helmet CPAP and Non-Invasive Positive Pressure Ventilation.|pdf=|usr=015}}
| |
| − | {{tp|p=C7274972|t=?. A Predictive Nomogram for Predicting Improved Clinical Outcome Probability in Patients with COVID-19 in Zhejiang Province China.|pdf=|usr=015}}
| |
| − | {{tp|p=32665947|t=2020. Ventilating two patients with one ventilator: technical setup and laboratory testing.|pdf=|usr=015}}
| |
| − | {{tp|p=C7239190|t=2020. COVID-19: (mis)managing an announced Black Swan.|pdf=|usr=015}}
| |
| − | {{tp|p=C7248588|t=?. The Story behind COVID-19: Animal Diseases at the Crossroads of Wildlife Livestock and Human Health.|pdf=|usr=015}}
| |
| − | {{tp|p=32665772|t=2020. Pathophysiology and therapy of systemic vasculitides.|pdf=|usr=015}}
| |
| − | {{tp|p=C7305929|t=2020. A machine learning model to identify early stage symptoms of SARS-Cov-2 infected patients.|pdf=|usr=015}}
| |
| − | {{tp|p=32671084|t=2020. Randomized Controlled Study Evaluating Efficiency of Low Intensity Transcranial Direct Current Stimulation (tDCS) for Dyspnea Relief in Mechanically Ventilated COVID-19 Patients in ICU: The tDCS-DYSP-COVID Protocol.|pdf=|usr=015}}
| |
| − | {{tp|p=32670066|t=2020. Pharmacotherapics Advice in Guidelines for COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32670073|t=2020. The Contribution of Surface Tension-Dependent Alveolar Septal Stress Concentrations to Ventilation-Induced Lung Injury in the Acute Respiratory Distress Syndrome.|pdf=|usr=015}}
| |
| − | {{tp|p=C7340039|t=?. Pandemic COVID-19: current status and challenges of antiviral therapies.|pdf=|usr=015}}
| |
| − | {{tp|p=C7318982|t=2020. Development of a vulnerability index for diagnosis with the novel coronavirus COVID-19 in Washington State USA.|pdf=|usr=015}}
| |
| − | {{tp|p=C7346788|t=?. Precautions for weaning from invasive mechanical ventilation with critically ill COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7280171|t=?. ASI?s Consensus Guidelines: ABCs of What to Do and What Not During the COVID-19 Pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=C7295495|t=2020. Data analytics for novel coronavirus disease.|pdf=|usr=015}}
| |
| − | {{tp|p=C7247958|t=?. The novel coronavirus 2019-nCoV: Its evolution and transmission into humans causing global COVID-19 pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=C7280134|t=?. Considerations for development and use of AI in response to COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7280123|t=?. Impact of Digital Surge during Covid-19 Pandemic: A Viewpoint on Research and Practice.|pdf=|usr=015}}
| |
| − | {{tp|p=C7255319|t=2020. Artificial intelligence and COVID-19: A multidisciplinary approach.|pdf=|usr=015}}
| |
| − | {{tp|p=C7283709|t=?. Reducing aerosol dispersion by High Flow Therapy in COVID?19: High Resolution Computational Fluid Dynamics Simulations of Particle Behavior during High Velocity Nasal Insufflation with a Simple Surgical Mask.|pdf=|usr=015}}
| |
| − | {{tp|p=C7280651|t=?. Aerosol Risk with Noninvasive Respiratory Support in Patients with COVID?19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7332908|t=?. Dissociation of Arterial Oxygen Saturation and Oxygen Delivery in VV-ECMO: The Trend Is Your Friend.|pdf=|usr=015}}
| |
| − | {{tp|p=32690235|t=?. Novel Closed-Loop Bronchoscopy Barrier Sheath: Valuable Addition for One-Lung Ventilation During the Coronavirus Disease 2019 Pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=C7216769|t=?. COVID-19: A Risk Assessment Perspective.|pdf=|usr=015}}
| |
| − | {{tp|p=32661797|t=?. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.|pdf=|usr=015}}
| |
| − | {{tp|p=32683213|t=2020. Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients.|pdf=|usr=015}}
| |
| − | {{tp|p=32670925|t=2020. Novel coronavirus: A capsule review for primary care and acute care physicians.|pdf=|usr=015}}
| |
| − | {{tp|p=32670981|t=2020. COVID-19 ? An avoidable epidemic: A family medicine practitioner s perspective.|pdf=|usr=015}}
| |
| − | {{tp|p=32671115|t=2020. The Pathogenesis of Coronavirus Disease 2019 (COVID-19): Evaluation and Prevention.|pdf=|usr=015}}
| |
| − | {{tp|p=32682658|t=?. Comparing Chinese children and adults with RT-PCR positive COVID-19: A systematic review.|pdf=|usr=015}}
| |
| − | {{tp|p=C7260515|t=2020. Prone Position of Patients With COVID-19 and Acute Respiratory Distress Syndrome.|pdf=|usr=015}}
| |
| − | {{tp|p=C7307021|t=?. Guidance for the Treatment and Management of COVID?19 Among People with Intellectual Disabilities.|pdf=|usr=015}}
| |
| − | {{tp|p=32734888|t=2020. COVID19: Challenging tissue viability in both patients and clinicians.|pdf=|usr=015}}
| |
| − | {{tp|p=C7250774|t=?. Risk-Stratifying COVID-19 Patients the Right Way?.|pdf=|usr=015}}
| |
| − | {{tp|p=C7301074|t=2020. Cardiac Dysfunction and Shock in Pediatric Patients With COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7293521|t=2020. COVID-19: My Perspective.|pdf=|usr=015}}
| |
| − | {{tp|p=C7351424|t=2020. Machine learning for COVID-19?asking the right questions.|pdf=|usr=015}}
| |
| − | {{tp|p=C7324107|t=2020. Digital tools against COVID-19: taxonomy ethical challenges and navigation aid.|pdf=|usr=015}}
| |
| − | {{tp|p=C7324116|t=?. COVID-19 in children and young people.|pdf=|usr=015}}
| |
| − | {{tp|p=C7274574|t=2020. Nano-enabled biosensing systems for intelligent healthcare: towards COVID-19 management.|pdf=|usr=015}}
| |
| − | {{tp|p=C7254035|t=2020. Resilient and agile engineering solutions to address societal challenges such as coronavirus pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=C7309744|t=?. Review on machine and deep learning models for the detection and prediction of Coronavirus.|pdf=|usr=015}}
| |
| − | {{tp|p=C7351032|t=?. Catalysis-in-a-Box: Robotic Screening of Catalytic Materials in the Time of COVID-19 and Beyond.|pdf=|usr=015}}
| |
| − | {{tp|p=C7306725|t=?. Mayo Clinic Strategies for COVID-19 Analytics and Prediction Modeling During the COVID-19 Pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=C7275154|t=2020. Innovation Lessons From the COVID-19 Pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=C7300530|t=?. MADVent: A low?cost ventilator for patients with COVID?19.|pdf=|usr=015}}
| |
| − | {{tp|p=32690325|t=?. When success means focusing on the oxygen delivery. A case of conventional management of severe hypoxemia in SARS-CoV-2.|pdf=|usr=015}}
| |
| − | {{tp|p=32670520|t=2020. Children in Coronaviruses? Wonderland: What Clinicians Need to Know.|pdf=|usr=015}}
| |
| − | {{tp|p=32690356|t=?. COVID-19 and respiratory support devices.|pdf=|usr=015}}
| |
| − | {{tp|p=C7212951|t=?. COVID-19 ? What does a paediatrician need to know?|pdf=|usr=015}}
| |
| − | {{tp|p=C7351392|t=?. COVID- 19 un Syndrome de Détresse Respiratoire Aigu atypique.|pdf=|usr=015}}
| |
| − | {{tp|p=C7243773|t=?. Rethinking COVID-19 in children: Lessons learned from pediatric viral and inflammatory cardiovascular diseases.|pdf=|usr=015}}
| |
| − | {{tp|p=C7240270|t=?. Neurocovid: Pharmacological recommendations for delirium associated with COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7233385|t=?. How Might AI and Chest Imaging Help Unravel COVID-19?s Mysteries?|pdf=|usr=015}}
| |
| − | {{tp|p=C7241405|t=2020. Human Coronavirus Infections?Severe Acute Respiratory Syndrome (SARS) Middle East Respiratory Syndrome (MERS) and SARS-CoV-2.|pdf=|usr=015}}
| |
| − | {{tp|p=32702720|t=?. Epidemiologic Clinical and Laboratory Findings of the COVID-19 in the current pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=32707480|t=2020. Respiratory support in patients with COVID-19 (outside intensive care unit). A position paper of the Respiratory Support and Chronic Care Group of the French Society of Respiratory Diseases.|pdf=|usr=015}}
| |
| − | {{tp|p=C7293480|t=?. Necrotizing tracheobronchitis with endotracheal tube obstruction in COVID-19 patients?.|pdf=|usr=015}}
| |
| − | {{tp|p=C7346828|t=?. Fisioterapia respiratoria con cinturones de vibración en el paciente crítico Covid-19 en posición de prono.|pdf=|usr=015}}
| |
| − | {{tp|p=32709450|t=?. Oxigenoterapia de alto flujo y posición de prono con respiración espontánea en neumonía por SARS-CoV-2.|pdf=|usr=015}}
| |
| − | {{tp|p=C7328544|t=2020. Présentation atypique du Covid-19 chez le jeune enfant.|pdf=|usr=015}}
| |
| − | {{tp|p=C7332461|t=?. COVID-19: Clinical aspects and therapeutics responses.|pdf=|usr=015}}
| |
| − | {{tp|p=32660623|t=2020. National Early Warning Score 2 (NEWS2) on admission predicts severe disease and in-hospital mortality from Covid-19 ? a prospective cohort study.|pdf=|usr=015}}
| |
| − | {{tp|p=C7301626|t=?. CPAP Added to Oxygen Administration Avoid Intubation in Acute Respiratory Distress in COVID-19 Pneumonia. Case Report.|pdf=|usr=015}}
| |
| − | {{tp|p=C7270519|t=?. Compartmental Models of the COVID-19 Pandemic for Physicians and Physician-Scientists.|pdf=|usr=015}}
| |
| − | {{tp|p=C7293183|t=2020. Growth detection quantification and inactivation of SARS-CoV-2.|pdf=|usr=015}}
| |
| − | {{tp|p=C7286215|t=?. Empfehlungen für ECMO bei COVID-19-Patienten: Consensus Paper zur Extrakorporalen Membranoxygenierung der Medizinischen Universität Wien.|pdf=|usr=015}}
| |
| − | head
| |
| − | {{tp|p=C7352094|t=2020. COVID-19 from mysterious enemy to an environmental detection process: a critical review.|pdf=|usr=015}}
| |
| − | {{tp|p=C7335662|t=?. A review of mathematical modeling artificial intelligence and datasets used in the study prediction and management of COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7335411|t=?. The effects of personal protective equipment on airway management: An in-situ simulation.|pdf=|usr=015}}
| |
| − | {{tp|p=C7334126|t=2020. Antivirals/direct oral anticoagulants interaction: Anticoagulation drug level increased and off label use: 12 case reports.|pdf=|usr=015}}
| |
| − | {{tp|p=C7330532|t=2020. The COVID-19 pandemic: biological evolution treatment options and consequences.|pdf=|usr=015}}
| |
| − | {{tp|p=C7323663|t=2020. Minireview of progress in the structural study of SARS-CoV-2 proteins.|pdf=|usr=015}}
| |
| − | {{tp|p=C7322402|t=?. On COVID-19 Modelling.|pdf=|usr=015}}
| |
| − | {{tp|p=C7306186|t=2020. Predictive Data Mining Models for Novel Coronavirus (COVID-19) Infected Patients? Recovery.|pdf=|usr=015}}
| |
| − | {{tp|p=C7305860|t=?. Affordable Compact and Infection-Free BiPAP Machine.|pdf=|usr=015}}
| |
| − | {{tp|p=C7304399|t=?. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection???.|pdf=|usr=015}}
| |
| − | {{tp|p=C7299854|t=?. Is the prone position indicated in critically ill patients with SARS-CoV-2 during the peri-operative period?|pdf=|usr=015}}
| |
| − | {{tp|p=C7298508|t=2020. COVID-19 with pulmonary involvement. An autoimmune disease of known cause☆.|pdf=|usr=015}}
| |
| − | {{tp|p=C7286705|t=?. Mechanical Ventilator Using Motorized Bellow.|pdf=|usr=015}}
| |
| − | {{tp|p=C7289234|t=2020. Forecasting Models for Coronavirus Disease (COVID-19): A Survey of the State-of-the-Art.|pdf=|usr=015}}
| |
| − | {{tp|p=C7280658|t=2020. COVID?19: a brief history and treatments in development.|pdf=|usr=015}}
| |
| − | {{tp|p=C7295269|t=2020. COVID-19: Beyond Respiratory Tract.|pdf=|usr=015}}
| |
| − | {{tp|p=C7205683|t=2020. The SARS-CoV-2 a new pandemic zoonosis that threatens the world?.|pdf=|usr=015}}
| |
| − | {{tp|p=C7181969|t=2020. Discussion on Etiology and Pathogenesis of Corona Virus Disease 2019 from ?Cold-dampness and Insidious Dryness?.|pdf=|usr=015}}
| |
| − | {{tp|p=C7323027|t=?. Novel use of home pulse oximetry monitoring in COVID?19 patients discharged from the emergency department identifies need for hospitalization.|pdf=|usr=015}}
| |
| − | {{tp|p=C7305492|t=2020. Where are we with understanding of COVID-19?|pdf=|usr=015}}
| |
| − | {{tp|p=C7300900|t=?. Recommendations for the prevention and treatment of the novel coronavirus pneumonia in the elderly in China.|pdf=|usr=015}}
| |
| − | {{tp|p=C7273077|t=?. Diagnosis and treatment strategy of coronavirus disease 2019 with cardiovascular disease in elderly patients.|pdf=|usr=015}}
| |
| − | {{tp|p=C7332921|t=?. SARS-CoV2 coronavirus: So far polite with children. Debatable immunological and non-immunological evidence.|pdf=|usr=015}}
| |
| − | {{tp|p=32713604|t=?. Consistency and reliability of COVID-19 projection models as a means to save lives.|pdf=|usr=015}}
| |
| − | {{tp|p=C7354270|t=?. Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease.|pdf=|usr=015}}
| |
| − | {{tp|p=C7351030|t=?. A novel inline PEEP valve design for differential multi-ventilation.|pdf=|usr=015}}
| |
| − | {{tp|p=32712236|t=?. Propofol in COVID 19 ? From basic science to clinical impact.|pdf=|usr=015}}
| |
| − | {{tp|p=32690223|t=?. The authors response: Propofol in COVID 19: From basic science to clinical impact?.|pdf=|usr=015}}
| |
| − | {{tp|p=C7335247|t=?. Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS.|pdf=|usr=015}}
| |
| − | {{tp|p=C7315940|t=?. Bayes theorem COVID19 and screening tests.|pdf=|usr=015}}
| |
| − | {{tp|p=32732086|t=?. Propofol and sedation in patients with coronavirus disease.|pdf=|usr=015}}
| |
| − | {{tp|p=32659413|t=?. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7267457|t=2020. Guidance for evaluating and testing patients for COVID?19.|pdf=|usr=015}}
| |
| − | {{tp|p=32659455|t=?. No added value of the modified NEWS score to predict clinical deterioration in COVID-19 patients.|pdf=|usr=015}}
| |
| − | {{tp|p=C7179066|t=2020. Airway Management in COVID-19: In the Den of the Beast.|pdf=|usr=015}}
| |
| − | {{tp|p=C7179060|t=2020. An Interim Solution to the Decreased Availability of Respirators Against COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7332953|t=?. Reinventing the Wheel in ARDS: Awake Proning in COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32682580|t=?. Mechanical Risks of Ventilator Sharing in the COVID-19 Era: A Simulation-Based Study.|pdf=|usr=015}}
| |
| − | {{tp|p=C7307707|t=?. An Introduction to COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7273864|t=2020. COVID-19 Update.|pdf=|usr=015}}
| |
| − | {{tp|p=32639742|t=?. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis.|pdf=|usr=015}}
| |
| − | {{tp|p=C7347420|t=2020. Machine learning to assist clinical decision-making during the COVID-19 pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=C7316646|t=2020. COVID-19: How to Use a Jet Nebulizer for Drug Administration in Ventilated Patients without Putting the Healthcare Workers at Risk.|pdf=|usr=015}}
| |
| − | {{tp|p=C7263230|t=?. Comprehensive review of coronavirus disease 2019 (COVID-19).|pdf=|usr=015}}
| |
| − | {{tp|p=C7332915|t=2020. Natural history of COVID-19 and current knowledge on treatment therapeutic options.|pdf=|usr=015}}
| |
| − | {{tp|p=C7299243|t=?. Inhaler with electrostatic sterilizer and use of cationic amphiphilic peptides may accelerate recovery from COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32682550|t=?. Interdependence between elevated intra-abdominal pleural and airway opening pressure in severe acute respiratory distress syndrome with extracorporeal membrane oxygenation.|pdf=|usr=015}}
| |
| − | {{tp|p=32680606|t=?. Airway management lessons from case reports of negative outcomes. Comment on Br J Anaesth; 125: e168?70.|pdf=|usr=015}}
| |
| − | {{tp|p=32718725|t=?. Regulating inspiratory pressure to individualise tidal volumes in a simulated two-patient one-ventilator system.|pdf=|usr=015}}
| |
| − | {{tp|p=32731958|t=?. COVID-19: a complex multisystem disorder.|pdf=|usr=015}}
| |
| − | {{tp|p=C7357972|t=?. What unusual symptoms to seek for COVID-19?|pdf=|usr=015}}
| |
| − | {{tp|p=32670617|t=2020. Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019-associated Acute Respiratory Distress Syndrome: An Initial US Experience at a High-volume Centre.|pdf=|usr=015}}
| |
| − | {{tp|p=C7314428|t=?. Emerging Technologies for Use in the Study Diagnosis and Treatment of Patients with COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=C7315944|t=2020. Applications of machine learning and artificial intelligence for Covid-19 (SARS-CoV-2) pandemic: A review.|pdf=|usr=015}}
| |
| − | {{tp|p=C7256553|t=?. Role of Intelligent Computing in COVID-19 Prognosis: A State-of-the-Art Review.|pdf=|usr=015}}
| |
| − | {{tp|p=C7344049|t=2020. Current strategies against COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32659224|t=2020. COVID-19: Review and hematologic impact.|pdf=|usr=015}}
| |
| − | {{tp|p=32659638|t=2020. From encephalitis lethargica to COVID-19: Is there another epidemic ahead?|pdf=|usr=015}}
| |
| − | {{tp|p=32665103|t=?. Hypofractionated Accelerated Concurrent Chemoradiotherapy in Inoperable Stage III Non-small Cell Lung Cancer: SOCCAR. A Large Single-Centre Experience.|pdf=|usr=015}}
| |
| − | {{tp|p=32665007|t=2020. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome.|pdf=|usr=015}}
| |
| − | {{tp|p=32671354|t=2020. Percutaneous Tracheostomy With Apnea During Coronavirus Disease 2019 Era: A Protocol and Brief Report of Cases.|pdf=|usr=015}}
| |
| − |
| |
| − | {{tp|p=32617354|t=2020. Clinical Characteristics of Children with COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32611498|t=2020. The authors' response: Propofol and sedation in patients with coronavirus disease 2019.|pdf=|usr=015}}
| |
| − | {{tp|p=32401039|t=2020. Glycemic control of type 2 diabetic patients with coronavirus disease during hospitalization: a proposal for early insulin therapy.|pdf=|usr=015}}
| |
| − | {{tp|p=32616399|t=2020. Insuficiencia respiratoria COVID-19: soporte con ECMO para ninos y adultos jovenes.|pdf=|usr=015}}
| |
| − | {{tp|p=32651097|t=2020. Implementation of a non-invasive oxygenation support strategy during the COVID-19 pandemic in an ephemeral Respiratory Intermediate Care Unit.|pdf=|usr=015}}
| |
| − | {{tp|p=32418868|t=2020. Ventilating multiple patients on a single ventilator: Statement from the French Society of Anaesthesia and Intensive Care (SFAR).|pdf=|usr=015}}
| |
| − | {{tp|p=32467451|t=2020. Shared Ventilation: Toward Safer Ventilator Splitting in Resource Emergencies.|pdf=|usr=015}}
| |
| − | {{tp|p=32358251|t=2020. Remote Control and Monitoring of GE Aisys Anesthesia Machines Repurposed as Intensive Care Unit Ventilators.|pdf=|usr=015}}
| |
| − | {{tp|p=32653361|t=2020. Permissive apnea in CoVid 19 Tracheostomy: alternative healthworkers safe procedure in Intensive Care Unit.|pdf=|usr=015}}
| |
| − | {{tp|p=32647717|t=2020. Hemodynamic monitoring in patients with venoarterial extracorporeal membrane oxygenation.|pdf=|usr=015}}
| |
| − | {{tp|p=32617313|t=2020. COVID-19: unravelling the clinical progression of nature's virtually perfect biological weapon.|pdf=|usr=015}}
| |
| − | {{tp|p=32427223|t=2020. Viral G-quadruplexes: New frontiers in virus pathogenesis and antiviral therapy.|pdf=|usr=015}}
| |
| − | {{tp|p=32599438|t=2020. Handling children in COVID wards: A narrative experience and suggestions for providing psychological support.|pdf=|usr=015}}
| |
| − | {{tp|p=32247712|t=2020. Preliminary Findings on Control of Dispersion of Aerosols and Droplets During High-Velocity Nasal Insufflation Therapy Using a Simple Surgical Mask: Implications for the High-Flow Nasal Cannula.|pdf=|usr=015}}
| |
| − | {{tp|p=32358325|t=2020. Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7).|pdf=|usr=015}}
| |
| − | {{tp|p=32118643|t=2020. Extracorporeal membrane oxygenation support in 2019 novel coronavirus disease: indications, timing, and implementation.|pdf=|usr=015}}
| |
| − | {{tp|p=32301757|t=2020. Interpretations of "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7)".|pdf=|usr=015}}
| |
| − | {{tp|p=32209887|t=2020. Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment.|pdf=|usr=015}}
| |
| − | {{tp|p=32011673|t=2020. Origin and Evolution of the 2019 Novel Coronavirus.|pdf=|usr=015}}
| |
| − | {{tp|p=32508025|t=2020. Improved mechanical ventilation requires more than just increased ventilator availability: A word of caution.|pdf=|usr=015}}
| |
| − | {{tp|p=32410701|t=2020. Safe doubling of ventilator capacity: a last resort proposal for last resorts.|pdf=|usr=015}}
| |
| − | {{tp|p=32576273|t=2020. Mobilization practices in critically ill children: a European point prevalence study (EU PARK-PICU).|pdf=|usr=015}}
| |
| − | {{tp|p=32426741|t=2020. Using the Surviving Sepsis Coronavirus Disease 2019 Guidelines-Anything New Yet?|pdf=|usr=015}}
| |
| − | {{tp|p=32618698|t=2020. Extracorporeal Membrane Oxygenation During the Coronavirus Disease 2019 Pandemic.|pdf=|usr=015}}
| |
| − | {{tp|p=32541567|t=2020. Adult Extracorporeal Membrane Oxygenation Patient Selection During Coronavirus Disease 2019: The Value of a Review Panel During Coronavirus Disease 2019.|pdf=|usr=015}}
| |
| − | {{tp|p=32656006|t=2020. Clinical Perspective on 2019 Novel Coronavirus Pneumonia: A Systematic Review of Published Case Reports.|pdf=|usr=015}}
| |
| − | {{tp|p=32623267|t=2020. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.|pdf=|usr=015}}
| |
| − | {{tp|p=32316503|t=2020. Artificial Intelligence in Radiology-Ethical Considerations.|pdf=|usr=015}}
| |
| − | {{tp|p=32218651|t=2020. Coronavirus outbreaks: prevention and management recommendations.|pdf=|usr=015}}
| |
| − | {{tp|p=32246897|t=2020. 10 Questions and 4 experts on Corona: Answers by Akiko Iwasaki, Gerard Krause, Samuel Alizon, and Rino Rappuoli.|pdf=|usr=015}}
| |
| − | {{tp|p=32430424|t=2020. Will children reveal their secret? The coronavirus dilemma.|pdf=|usr=015}}
| |
| − | {{tp|p=32398300|t=2020. Will children reveal their secret? The coronavirus dilemma.|pdf=|usr=015}}
| |
| − | {{tp|p=32430433|t=2020. A predictive model for disease progression in non-severely ill patients with coronavirus disease 2019.|pdf=|usr=015}}
| |
| − | {{tp|p=32612430|t=2020. Unclear Issues Regarding COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32582575|t=2020. A Novel Scoring System for Prediction of Disease Severity in COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32612615|t=2020. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19.|pdf=|usr=015}}
| |
| − | {{tp|p=32656172|t=2020. Children Infected With SARS-CoV-2 From Family Clusters.|pdf=|usr=015}}
| |
| − | {{tp|p=32626682|t=2020. The COVID-19 Diagnostic Technology Landscape: Efficient Data Sharing Drives Diagnostic Development.|pdf=|usr=015}}
| |
| − | {{tp|p=32612971|t=2020. Clinical Features of 33 Cases in Children Infected With SARS-CoV-2 in Anhui Province, China-A Multi-Center Retrospective Cohort Study.|pdf=|usr=015}}
| |
| − | {{tp|p=32550291|t=2020. Technological developments driven by COVID.|pdf=|usr=015}}
| |
| − | {{tp|p=32655724|t=2020. Coronavirus Disease 2019: A Gastroenterologist's Perspective in May 2020.|pdf=|usr=015}}
| |
| − | {{tp|p=32636036|t=2020. Covid-19 treatment-induced neuropsychiatric adverse effects.|pdf=|usr=015}}
| |
| − | {{tp|p=32292829|t=2020. Interpretation of the diagnosis and treatment plan of Corona Virus Disease 2019 (tentative fifth revised edition).|pdf=|usr=015}}
| |
| − | {{tp|p=32542185|t=2020. The application of DNA nucleotide footprint plotting in coronavirus.|pdf=|usr=015}}
| |
| − | {{tp|p=32502776|t=2020. Remote ischemic preconditioning: Lung protection in the time of a pandemic?|pdf=|usr=015}}
| |
| − | {{tp|p=32540385|t=2020. Pandemics and methodological developments in epidemiology history.|pdf=|usr=015}}
| |
| − | {{tp|p=32652215|t=2020. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approach.|pdf=|usr=015}}
| |
| − | {{tp|p=32220077|t=2020. A survey of 434 clinical trials about coronavirus disease 2019 in China.|pdf=|usr=015}}
| |
| − | {{tp|p=32508437|t=2020. Coronavirus disease-2019: A brief compilation of facts.|pdf=|usr=015}}
| |
| − | {{tp|p=32202014|t=2020. Three children who recovered from novel coronavirus 2019 pneumonia.|pdf=|usr=015}}
| |
| − | {{tp|p=32651882|t=2020. Guidance for Healthcare Providers Managing COVID-19 in Rural and Underserved Areas.|pdf=|usr=015}}
| |
| − | {{tp|p=32151778|t=2020. Coronaviruses: Facts, Myths, and Hypotheses.|pdf=|usr=015}}
| |
| − | {{tp|p=32487914|t=2020. Mitigating Pressure Injury Challenges When Placing Patients in a Prone Position: A View From Here.|pdf=|usr=015}}
| |
| − | {{tp|p=32653054|t=2020. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study.|pdf=|usr=015}}
| |
| − | {{tp|p=31876329|t=2019. MASS SPECTROMETRY IN VIROLOGICAL SCIENCES.|pdf=|usr=015}}
| |
| − | {{tp|p=32493646|t=2020. Sharing a single ventilator ("In vitro").|pdf=|usr=015}}
| |
| − | {{tp|p=32651570|t=2020. CRISPRing for host genes regulating SARS-CoV-2.|pdf=|usr=015}}
| |
| − | {{tp|p=32287783|t=2020. Chinese illness caused by a virus.|pdf=|usr=015}}
| |
| − | {{tp|p=32536725|t=2020. SARS-CoV-2 Infektion bei Kindern und Jugendlichen: Ein Literaturuberblick der AG Infektiologie der OGKJ1.|pdf=|usr=015}}
| |
| − | {{tp|p=32618678|t=2020. Coronavirus Disease 2019: Understanding Immunopathogenesis Is the "Holy Grail" to Explain Why Children Have Less Severe Acute Disease.|pdf=|usr=015}}
| |
| − | {{tp|p=32314538|t=2020. Why is Coronavirus Disease 2019 not as severe in children?-A look at type 2 alveolar cells.|pdf=|usr=015}}
| |
| − | {{tp|p=32511881|t=2020. Pediatric coronavirus disease-2019: How to assess chest disease?|pdf=|usr=015}}
| |
| − | {{tp|p=32621013|t=2020. Management strategies for children with COVID-19: ESPR practical recommendations.|pdf=|usr=015}}
| |
| − | {{tp|p=32656001|t=2020. Hemogram data as a tool for decision-making in COVID-19 management: applications to resource scarcity scenarios.|pdf=|usr=015}}
| |
| − | {{tp|p=32653383|t=2020. Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020.|pdf=|usr=015}}
| |
| − | {{tp|p=32394505|t=2020. The 2019 human coronavirus: Ten areas of uncertainty waiting to be resolved.|pdf=|usr=015}}
| |
| − | {{tp|p=32636686|t=2020. COVID-19 in Children: An Ample Review.|pdf=|usr=015}}
| |
| − | {{tp|p=32424018|t=2020. A rapidly deployable individualized system for augmenting ventilator capacity.|pdf=|usr=015}}
| |
| − | {{tp|p=32651686|t=2020. COVID-19: clinical issues from the Japan Surgical Society.|pdf=|usr=015}}
| |
| − | {{tp|p=32392018|t=2020. Time Course of Evolving Ventilator-Induced Lung Injury: The "Shrinking Baby Lung".|pdf=|usr=015}}
| |
| − |
| |
| − | {{tp|p=32645474|t=2020. Environmental Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) from Medical Equipment in Long-Term Care Facilities undergoing COVID-19 Outbreaks.|pdf=|usr=012}}
| |
| − | {{tp|p=32645473|t=2020. Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: impact on the reutilization of disposable devices.|pdf=|usr=012}}
| |
| − | {{tp|p=32620220|t=2020. A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32619530|t=2020. Supraglottic airways in the management of COVID-19 patients.|pdf=|usr=012}}
| |
| − | {{tp|p=32635743|t=2020. Enhancing colorimetric loop-mediated isothermal amplification speed and sensitivity with guanidine chloride.|pdf=|usr=012}}
| |
| − | {{tp|p=32624495|t=2020. Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service.|pdf=|usr=012}}
| |
| − | {{tp|p=32624494|t=2020. Improved survival following ward-based non-invasive pressure support for severe hypoxia in a cohort of frail patients with COVID-19: retrospective analysis from a UK teaching hospital.|pdf=|usr=012}}
| |
| − | {{tp|p=32646518|t=2020. Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?|pdf=|usr=012}}
| |
| − | {{tp|p=32646506|t=2020. Classification of COVID-19 in intensive care patients.|pdf=|usr=012}}
| |
| − | {{tp|p=32646470|t=2020. Impact of initial respiratory compliance in ventilated patients with acute respiratory distress syndrome related to COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32646469|t=2020. Angiotensin II treatment in COVID-19 patients: more risk than benefit? A single-center experience.|pdf=|usr=012}}
| |
| − | {{tp|p=32646456|t=2020. Transpulmonary pressure in SARS-CoV-2-associated acute respiratory distress syndrome: a single-center observational study.|pdf=|usr=012}}
| |
| − | {{tp|p=32616077|t=2020. Acute complications and mortality in hospitalized patients with coronavirus disease 2019: a systematic review and meta-analysis.|pdf=|usr=012}}
| |
| − | {{tp|p=32645614|t=2020. Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019.|pdf=|usr=012}}
| |
| − | {{tp|p=32639930|t=2020. Effectiveness of Cloth Masks for Protection Against Severe Acute Respiratory Syndrome Coronavirus 2.|pdf=|usr=012}}
| |
| − | {{tp|p=32614768|t=2020. High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020.|pdf=|usr=012}}
| |
| − | {{tp|p=32632766|t=2020. Transcatheter drug delivery through bronchial artery for COVID-19: is it fiction or could it come true?|pdf=|usr=012}}
| |
| − | {{tp|p=32631837|t=2020. Rationale and significance of patient selection in awake prone positioning for COVID-19 pneumonia.|pdf=|usr=012}}
| |
| − | {{tp|p=32616591|t=2020. COVID-19 phenotypes: leading or misleading?|pdf=|usr=012}}
| |
| − | {{tp|p=32471937|t=2020. What do differences in case fatality ratios between children and adults tell us about COVID-19?|pdf=|usr=012}}
| |
| − | {{tp|p=32430425|t=2020. What do differences in case fatality ratios between children and adults tell us about COVID-19?|pdf=|usr=012}}
| |
| − | {{tp|p=32638337|t=2020. COVID-19 in Children: Clinical Approach and Management- Correspondence.|pdf=|usr=012}}
| |
| − | {{tp|p=32615256|t=2020. Predicting Severe Outcomes in COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32635289|t=2020. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System.|pdf=|usr=012}}
| |
| − | {{tp|p=32619697|t=2020. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound?|pdf=|usr=012}}
| |
| − | {{tp|p=32645311|t=2020. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted?|pdf=|usr=012}}
| |
| − | {{tp|p=32630780|t=2020. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science.|pdf=|usr=012}}
| |
| − | {{tp|p=32611701|t=2020. Increasing Temperature and Relative Humidity Accelerates Inactivation of SARS-CoV-2 on Surfaces.|pdf=|usr=012}}
| |
| − | {{tp|p=32613257|t=2020. Grundlagen der Replikation und der Immunologie von SARS-CoV-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32639466|t=2020. Clinical Features of Critical Coronavirus Disease 2019 in Children.|pdf=|usr=012}}
| |
| − | {{tp|p=32614258|t=2020. High Incidence of Barotrauma in Patients with COVID-19 Infection on Invasive Mechanical Ventilation.|pdf=|usr=012}}
| |
| − | {{tp|p=32629100|t=2020. Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2.|pdf=|usr=012}}
| |
| − | {{tp|p=32641059|t=2020. The newly emerged COVID-19 disease: a systemic review.|pdf=|usr=012}}
| |
| − | {{tp|p=32621065|t=2020. Recommendations for extracorporeal membrane oxygenation (ECMO) in COVID-19 patients : Consensus paper of the Medical University of Vienna.|pdf=|usr=012}}
| |
| − | {{tp|p=32640088|t=2020. COVID-19 in Italian pediatric patients: the experience of a tertiary children's hospital.|pdf=|usr=012}}
| |
| − | {{tp|p=32618260|t=2020. Review of Burden, Clinical Definitions, and Management of COVID-19 Cases.|pdf=|usr=012}}
| |
| − | {{tp|p=32639236|t=2020. Differential Ventilation Using Flow Control Valves as a Potential Bridge to Full Ventilatory Support during the COVID-19 Crisis: From Bench to Bedside.|pdf=|usr=012}}
| |
| − | {{tp|p=32601086|t=2020. Critical paediatric COVID-19: varied presentations but good outcomes.|pdf=|usr=012}}
| |
| − | {{tp|p=32601085|t=2020. COVID-19: children on the front line.|pdf=|usr=012}}
| |
| − | {{tp|p=32639742|t=2020. The Potential of Various Nanotechnologies for Coronavirus Diagnosis/Treatment Highlighted through a Literature Analysis.|pdf=|usr=012}}
| |
| − | {{tp|p=32620682|t=2020. Against the odds: unlikely COVID-19 recovery.|pdf=|usr=012}}
| |
| − | {{tp|p=32640485|t=2020. CoVID-19 insights from transfusion medicine.|pdf=|usr=012}}
| |
| − | {{tp|p=32640484|t=2020. Blood Component Use in Critical Care in Patients with COVID-19 Infection: A Single Centre Experience.|pdf=|usr=012}}
| |
| − | {{tp|p=32611881|t=2020. Could it be COVID-19? Atypical presentations in a pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32611305|t=2020. Overview of Covid-19 regarding the cardiovascular situation in the light of current reports.|pdf=|usr=012}}
| |
| − | {{tp|p=32649747|t=2020. Personalized therapy approach for hospitalized patients with COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32649738|t=2020. Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia.|pdf=|usr=012}}
| |
| − | {{tp|p=32645717|t=2020. The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics.|pdf=|usr=012}}
| |
| − | {{tp|p=32646234|t=2020. COVID-19 Epidemic: Clinical Characteristics of Patients in Pediatric Isolation Ward.|pdf=|usr=012}}
| |
| − | {{tp|p=32633553|t=2020. Young Children Presenting With Fever and Rash in the Midst of SARS-CoV-2 Outbreak in New York.|pdf=|usr=012}}
| |
| − | {{tp|p=32633856|t=2020. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.|pdf=|usr=012}}
| |
| − | {{tp|p=32645276|t=2020. The COVID-19 pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32621728|t=2020. The optimal diagnostic methods for COVID-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32615022|t=2020. Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments.|pdf=|usr=012}}
| |
| − | {{tp|p=32636210|t=2020. Initial Observations of COVID-19 in US Children.|pdf=|usr=012}}
| |
| − | {{tp|p=32616087|t=2020. Interventions for healthcare professionals taking care of COVID-19 patients (beyond vaccines). A systematic review.|pdf=|usr=012}}
| |
| − | {{tp|p=32634058|t=2020. Has Venoarterial ECMO Been Underutilized in COVID-19 Patients?|pdf=|usr=012}}
| |
| − | {{tp|p=32618418|t=2020. Protecting prone positioned patients from facial pressure ulcers using prophylactic dressings: A timely biomechanical analysis in the context of the COVID-19 pandemic.|pdf=|usr=012}}
| |
| − | {{tp|p=32619398|t=2020. Classification of the COVID-19 infected patients using DenseNet201 based deep transfer learning.|pdf=|usr=012}}
| |
| − | {{tp|p=32641351|t=2020. Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection.|pdf=|usr=012}}
| |
| − | {{tp|p=32644215|t=2020. Early-stage predictors of the acute phase duration in uncomplicated COVID-19 pneumonia.|pdf=|usr=012}}
| |
| − | {{tp|p=32617987|t=2020. Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review.|pdf=|usr=012}}
| |
| − | {{tp|p=32648973|t=2020. Extra-pulmonary complications of COVID-19: a multi-system disease?|pdf=|usr=012}}
| |
| − | {{tp|p=32648899|t=2020. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.|pdf=|usr=012}}
| |
| − | {{tp|p=32640146|t=2020. Audio Interview: Acute Lung Injury in Covid-19.|pdf=|usr=012}}
| |
| − | {{tp|p=32633327|t=2020. SARS, MERS, COVID-19: Clinical Manifestations and Organ-System Complications: A Mini Review.|pdf=|usr=012}}
| |
| − | {{tp|p=32618932|t=2020. Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.|pdf=|usr=012}}
| |
| − | {{tp|p=32634818|t=2020. COVID-19 PICU guidelines: for high- and limited-resource settings.|pdf=|usr=012}}
| |
| − | {{tp|p=32615580|t=2020. COVID-19: Precautions with children in home mechanical ventilation.|pdf=|usr=012}}
| |
| − | {{tp|p=32643551|t=2020. Veno-venous extracorporeal membrane oxygenation for COVID-19-associated pediatric acute respiratory distress syndrome.|pdf=|usr=012}}
| |
| − | {{tp|p=32636278|t=2020. END-TIDAL-TO-ARTERIAL PCO2 RATIO AS SIGNIFIER FOR PHYSIOLOGIC DEAD-SPACE RATIO AND OXYGENATION DYSFUNCTION IN ACUTE RESPIRATORY DISTRESS SYNDROME.|pdf=|usr=012}}
| |
| − | {{tp|p=32644275|t=2020. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.|pdf=|usr=012}}
| |
| − |
| |
| − | {{tp|p=32413736|t=2020. Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids.|pdf=|usr=008}}
| |
| − | {{tp|p=32534188|t=2020. Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A global pandemic and treatments strategies.|pdf=|usr=008}}
| |
| − | {{tp|p=32315803|t=2020. Preliminary therapeutic drug monitoring data of beta-lactams in critically ill patients with SARS-CoV-2 infection.|pdf=|usr=008}}
| |
| − | {{tp|p=32532623|t=2020. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines.|pdf=|usr=008}}
| |
| − | {{tp|p=32390307|t=2020. Practical tips for using masks in the COVID-19 pandemic.|pdf=|usr=008}}
| |
| − | {{tp|p=32496248|t=2020. Effectiveness of preventive measures against COVID-19: A systematic review of In Silico modeling studies in indian context.|pdf=|usr=007}}
| |
| − | {{tp|p=32496246|t=2020. Impact of nonpharmacological interventions on COVID-19 transmission dynamics in India.|pdf=|usr=007}}
| |
| − | {{tp|p=32505040|t=2020. The end of 'cordon sanitaire' in Wuhan: the role of non-pharmaceutical interventions against COVID-19.|pdf=|usr=007}}
| |
| − | {{tp|p=32403134|t=2020. Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic.|pdf=|usr=007}}
| |
| − | {{tp|p=32512579|t=2020. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe.|pdf=|usr=007}}
| |
| − | {{tp|p=32116200|t=2020. COVID-19: Perspectives on the Potential Novel Global Threat.|pdf=|usr=007}}
| |
| − | {{tp|p=32463459|t=2020. Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States.|pdf=|usr=007}}
| |
| − | {{tp|p=32472939|t=2020. Assessing the impact of non-pharmaceutical interventions on SARS-CoV-2 transmission in Switzerland.|pdf=|usr=007}}
| |
| − | {{tp|p=32491981|t=2020. Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings-International Travel-Related Measures.|pdf=|usr=007}}
| |
| − | {{tp|p=32487283|t=2020. Effect of Nonpharmaceutical Interventions on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, South Korea, 2020.|pdf=|usr=007}}
| |
| − | {{tp|p=32407551|t=2020. Interrogation of the safety and efficacy of home-use light-based devices.|pdf=|usr=007}}
| |
| − | {{tp|p=32429705|t=2020. COVID-19 and Nutrition: The Need for Initiatives to Promote Healthy Eating and Prevent Obesity in Childhood.|pdf=|usr=007}}
| |
| − | {{tp|p=32325124|t=ä. Vaporization, bioactive formulations and a marine natural product: different perspectives on antivirals |pdf=|usr=}}
| |
| − | {{tp|p=32312129|t=2020. The role of additive manufacturing and antimicrobial polymers in the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32356251|t=ä. Medical Toxicology and COVID-19: Our Role in a Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32272857|t=2020. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks |pdf=|usr=}}
| |
| − | {{tp|p=32129977|t=2020. Cell-Membrane-Mimicking Nanodecoys against Infectious Diseases |pdf=|usr=}}
| |
| − | {{tp|p=29115746|t=2018. Progress Toward the Clinical Translation of Bioinspired Peptide and Protein Assemblies |pdf=|usr=}}
| |
| − | {{tp|p=29717819|t=2018. Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens |pdf=|usr=}}
| |
| − | {{tp|p=32426002|t=2020. Opciones Terapeuticas En El Manejo De Covid-19 Grave: Una Perspectiva De Reumatologia.|pdf=|usr=009}}
| |
| − | {{tp|p=32558354|t=2020. Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load.|pdf=|usr=010}}
| |
| − | {{tp|p=32562159|t=2020. The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.|pdf=|usr=010}}
| |
| − | {{tp|p=32565309|t=2020. Effect of combination antiviral therapy on hematological profiles in 151 adults hospitalized with severe coronavirus disease 2019.|pdf=|usr=010}}
| |
| − | {{tp|p=32593196|t=2020. The Another Side of COVID-19 in Alzheimer's Disease Patients: Drug-Drug Interactions.|pdf=|usr=010}}
| |
| − | {{tp|p=32520770|t=2020. Overview of Coronavirus Disease 2019 (COVID-19): Treatment Updates and Advances.|pdf=|usr=011}}
| |
| − | {{tp|p=32284797|t=2020. We have to write and share valid and reliable information on COVID-19.|pdf=|usr=009}}
| |
| − | {{tp|p=32487093|t=2020. The urgency of utilizing COVID-19 biospecimens for research in the heart of the global pandemic.|pdf=|usr=009}}
| |
| − | {{tp|p=32405428|t=2020. Summary of the coronavirus disease 2019 (COVID-19) update from the 2020 Conference on Retroviruses and Opportunistic Infections, 8-11 March 2020, Boston, USA.|pdf=|usr=009}}
| |
| − | {{tp|p=32425304|t=2020. Reflection on lower rates of COVID-19 in children: Does childhood immunizations offer unexpected protection?|pdf=|usr=009}}
| |
| − | {{tp|p=32393381|t=2020. Perceived infection transmission routes, infection control practices, psychosocial changes, and management of COVID-19 infected healthcare workers in a tertiary acute care hospital in Wuhan: a cross-sectional survey.|pdf=|usr=009}}
| |
| − | {{tp|p=32439309|t=2020. Revision narrativa sobre la respuesta inmunitaria frente a coronavirus: descripcion general, aplicabilidad para SARS-COV-2 e implicaciones terapeuticas.|pdf=|usr=008}}
| |
| − | {{tp|p=32504103|t=2020. Ten things we learned about COVID-19.|pdf=|usr=008}}
| |
| − | {{tp|p=32494929|t=2020. COVID-19: 10 things I wished I'd known some months ago.|pdf=|usr=008}}
| |
| − | {{tp|p=32546867|t=2020. Why children avoid the worst coronavirus complications might lie in their arteries.|pdf=|usr=011}}
| |
| − |
| |
| − | ===008===
| |
| − | {{tp|p=32502594|t=2020. Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32398183|t=2020. Just the Facts: What are the roles of oxygen escalation and noninvasive ventilation in COVID-19?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32471449|t=2020. COVID-19 pneumonia: phenotype assessment requires bedside tools.|pdf=|usr=008}}
| |
| − | {{tp|p=32414393|t=2020. Angiotensin II infusion in COVID-19-associated vasodilatory shock: a case series.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32517796|t=2020. Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32513249|t=2020. Prehospital pulse oximetry: a red flag for early detection of silent hypoxemia in COVID-19 patients.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32329539|t=2020. What ENT doctors should know about COVID-19 contagion risks.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32519004|t=2020. How likely are COVID-19 interventions to benefit the sickest patients?|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32489507|t=2020. A Comprehensive Approach Is Vital for Diagnosing COVID-19: A Case of False Negative.|pdf=|usr=008}}
| |
| − | {{tp|p=32298514|t=2020. Noncutaneous considerations of COVID-19 for dermatology practices.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32493671|t=2020. SARS, MERS and COVID-19 among healthcare workers: A narrative review.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32141619|t=2020. The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.|pdf=|usr=008}}
| |
| − | {{tp|p=32425996|t=2020. A Systematic Review of Asymptomatic Infections with COVID-19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32517833|t=2020. Disposition of patients with coronavirus disease 2019 (COVID-19) whose respiratory specimens remain positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) by polymerase chain reaction assay (PCR).|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32521580|t=2020. [Expert consensus on Corona Virus Disease 2019 with special blood purification technology].|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32458370|t=2020. Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide.|pdf=|usr=008}}
| |
| − | {{tp|p=32471584|t=2020. COVID-19 and Shock: A Cautionary Tale for Elderly Patients From a Pooled Analysis.|pdf=|usr=008}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32516429|t=2020. Anticoagulation with Argatroban in patients with acute antithrombin deficiency in severe COVID -19.|pdf=|usr=008}}
| |
| − |
| |
| − | {{tp|p=32278670|t=ä. SARS-Cov-2 in Spanish Intensive Care: Early Experience with 15-day Survival In Vitoria |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32188482|t=2020. COVID-19 infection epidemic: the medical management strategies in Heilongjiang Province, China |pdf=|usr=}}
| |
| − | {{tp|p=32151274|t=2020. Preparing for COVID-19: early experience from an intensive care unit in Singapore |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32307120|t=ä. Palliative care strategies offer guidance to clinicians and comfort for COVID-19 patient and families |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32167442|t=ä. Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32278795|t=ä. Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32353109|t=ä. COVID-19 Pandemic: Considerations for Safe Medication Use in Older Adults with Multimorbidity and Polypharmacy |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32318706|t=ä. Multicenter initial guidance on use of antivirals for children with COVID-19/SARS-CoV-2 |pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=32197787|t=2020. Recomendaciones practicas para el manejo perioperatorio ...|pdf=|usr=}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32270695|t=2020. Interim Guidance for Basic and Advanced Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: ... |pdf=|usr=}}
| |
| − | {{tp|p=32372742|t=ä. Asymptomatic SARS-CoV-2 infections: What do we need to know?|pdf=|usr=}}
| |
| − | {{tp|p=32135584|t=2020. Recommendations for the diagnosis, prevention and control of the 2019 novel coronavirus infection in children (first interim edition) |pdf=|usr=}}
| |
| − | {{ttp|p=32412013|t=2020. International Committee of the Red Cross (ICRC): General guidance for the management of the dead related to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7187741|t=ä. Clinical Ethical Challenges in the Covid-19 Crisis in South Africa |pdf=|usr=}}
| |
| − | {{tp|p=32227494|t=2020. Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32407441|t=2020. Assessment of Deaths From COVID-19 and From Seasonal Influenza.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32502334|t=2020. False Negative Tests for SARS-CoV-2 Infection - Challenges and Implications.|pdf=|usr=007}}
| |
| − | {{tp|p=32501664|t=2020. Waiting for Certainty on Covid-19 Antibody Tests - At What Cost?|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32439651|t=2020. CT Scanning in Suspected Stroke or Head Trauma: Is it Worth to go the Extra Mile and Include the Chest to Screen for COVID-19 Infection?|pdf=|usr=007}}
| |
| − | {{tp|p=32511784|t=2020. Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32209542|t=2020. Don't forget chronic lung and immune conditions during covid-19, says WHO.|pdf=|usr=007}}
| |
| − |
| |
| − | {{tp|p=32425326|t=2020. Cardiovascular Disease Novel Coronavirus and the Search for Investigational Therapies.|pdf=|usr=009}}
| |
| − |
| |
| − | {{tp|p=32412606|t=2020. Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit.|pdf=|usr=009}}
| |
| − |
| |
| − | {{tp|p=32405839|t=2020. Priorisierung von Pflegeheimbewohnern aus notfallmedizinischer Sicht : Corona-Pandemie 2020.|pdf=|usr=009}}
| |
| − | {{tp|p=32405838|t=2020. Herausforderungen fur die pflegerische Versorgung in der stationaren Altenhilfe : Corona-Pandemie 2020.|pdf=|usr=009}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32380803|t=2020. COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy.|pdf=|usr=009}}
| |
| − |
| |
| − | {{tp|p=32490031|t=2020. Differentiating Between 2019 Novel Coronavirus Pneumonia and Influenza Using a Nonspecific Laboratory Marker-Based Dynamic Nomogram.|pdf=|usr=009}}
| |
| − | {{tp|p=32267979|t=2020. COVID-19: The Uninvited Guest in the Intensive Care Unit - Implications for Pharmacotherapy.|pdf=|usr=009}}
| |
| − |
| |
| − | {{tp|p=32525022|t=2020. European Resuscitation Council COVID-19 guidelines executive summary.|pdf=|usr=009}}
| |
| − |
| |
| − | {{tp|p=32588922|t=2020. ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020).|pdf=|usr=010}}
| |
| − | {{tp|p=32538597|t=2020. Management of Fever in Infants and Young Children.|pdf=|usr=010}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32553046|t=2020. Emergence of Undetectable Malaria Parasites: A Threat under the Radar amid the COVID-19 Pandemic?|pdf=|usr=010}}
| |
| − |
| |
| − | {{tp|p=32586927|t=2020. Delayed access to care and late presentations in children during the COVID-19 pandemic: a snapshot survey of 4075 paediatricians in the UK and Ireland.|pdf=|usr=010}}
| |
| − | {{tp|p=32576565|t=2020. Double-edged sword of limiting healthcare provision for children in times of COVID-19: the hidden price we pay.|pdf=|usr=010}}
| |
| − |
| |
| − | {{tp|p=32588674|t=2020. COVID-19 Pneumonia and Immune-Related Pneumonitis: critical issues on differential diagnosis, potential interactions and management.|pdf=|usr=010}}
| |
| − |
| |
| − | {{tp|p=32586209|t=2020. COVID-19 lockdown in India triggers a rapid rise in suicides due to the alcohol withdrawal symptoms: Evidence from media reports.|pdf=|usr=010}}
| |
| − | {{tp|p=32583683|t=2020. On Masochism: A Resident's Conflict Between Sacrifice and Self-Preservation During the COVID-19 Pandemic.|pdf=|usr=010}}
| |
| − |
| |
| − | {{tp|p=32605549|t=2020. Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19).|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32416995|t=2020. Sevoflurane, a sigh of relief in COVID-19?|pdf=|usr=011}}
| |
| − | {{tp|p=32599018|t=2020. TRANSFUSION THRESHOLDS FOR ADULT RESPIRATORY EXTRACORPOREAL LIFE SUPPORT: AN EXPERT CONSENSUS DOCUMENT.|pdf=|usr=011}}
| |
| − |
| |
| − |
| |
| − | {{tp|p=32610172|t=2020. Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32553186|t=2020. Cover Illustration: "Lockdown" mural, Bath Street, Glasgow, by the.rebel.bearUnshackling Plastic Surgery from COVID-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32572386|t=2020. The National Institute of Allergy and Infectious Diseases Decision to Stop the Adaptive COVID-19 Trial: On Solid Ethical and Scientific Grounds.|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32248499|t=2020. Klug entscheiden : bei SARS-CoV-2 und anderen Infektionen.|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32302281|t=2020. Addressing Challenges in Obtaining Emergency Medicine Away Rotations and Standardized Letters of Evaluation Due to COVID-19 Pandemic.|pdf=|usr=011}}
| |
| − | {{tp|p=32591843|t=2020. Hazardous Postoperative Outcomes of Unexpected COVID-19 Infected Patients: A Call for Global Consideration of Sampling All Asymptomatic Patients Before Surgical Treatment.|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32603008|t=2020. The early experiences of a single tertiary Italian emergency department treating COVID-19 in children.|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32552415|t=2020. Atypical and novel presentations of Coronavirus Disease 2019: a case series of three children.|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32339268|t=2020. Angry viruses make us sick: a child's depiction of SARS-CoV-2.|pdf=|usr=011}}
| |
| − | {{tp|p=32574270|t=2020. Coronavirus Disease (Covid-19): What Are We Learning in a Country With High Mortality Rate?|pdf=|usr=011}}
| |
| − |
| |
| − | {{tp|p=32540464|t=2020. Usefulness of the epidemiological survey and RT-PCR test in pre-surgical patients for assessing the risk of Covid-19.|pdf=|usr=011}}
| |
| − | {{tp|p=32594893|t=2020. The attempted murder of a surgeon (1882): Frank Algernon Hall of Lewes, Sussex.|pdf=|usr=011}}
| |
